Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yousuke, Aoki"'
Autor:
Takafumi Nemoto, Atsuya Takeda, Yukinori Matsuo, Noriko Kishi, Takahisa Eriguchi, Etsuo Kunieda, Ryusei Kimura, Naoko Sanuki, Yuichiro Tsurugai, Masamichi Yagi, Yousuke Aoki, Yohei Oku, Yuto Kimura, Changhee Han, Naoyuki Shigematsu
Publikováno v:
JCO clinical cancer informatics. 6
PURPOSE Clear evidence indicating whether surgery or stereotactic body radiation therapy (SBRT) is best for non–small-cell lung cancer (NSCLC) is lacking. SBRT has many advantages. We used artificial neural networks (NNs) to predict treatment outco
Publikováno v:
Hepatology Research. 51:294-302
Aim Decisions regarding therapeutic plans for inoperable patients with hepatocellular carcinoma (HCC) adjacent to the gastrointestinal (GI) tract are challenging because radiofrequency ablation has the potential risk of thermal injury. Moreover, the
Autor:
Naoto Mikami, Atsuya Takeda, Aya Hashimoto, Toshiaki Takeda, Yuto Kimura, Yohei Oku, Yousuke Aoki, Takahisa Eriguchi, Yuichiro Tsurugai, Noriyuki Saeki, Tatsuji Enomoto, Hidehiko Kuribayashi, Makoto Masuda, Takeshi Kaneko
Publikováno v:
Clinical lung cancer. 23(5)
Stereotactic body radiotherapy (SBRT) has been rapidly evolving and increasingly performed in patients with ground-glass opacity (GGO) predominant lung cancer (GGOp-LC).To evaluate early-phase CT findings of GGOp-LC after SBRT.Patients with GGOp-LC s
Autor:
Yousuke Aoki, Takeshi Akiba, Takahisa Eriguchi, Naoko Sanuki, Atsuya Takeda, Yohei Oku, Etsuo Kunieda, Akitomo Sugawara, Yuichiro Tsurugai
Publikováno v:
Journal of Radiation Research
We retrospectively investigated outcomes, including pulmonary toxicities, of stereotactic body radiation therapy using RapidArc and a risk-adapted 60% isodose plan for early-stage non-small-cell lung cancer patients. We evaluated patients staged as c
Autor:
Naoko Sanuki, Yohei Oku, Atsuya Takeda, Noriyuki Saeki, Yousuke Aoki, Takeshi Kaneko, Tomikazu Mizuno, Yuichiro Tsurugai, Yu Hara, Etsuo Kunieda, Takeshi Akiba, Tatsuji Enomoto
Publikováno v:
Radiotherapy and Oncology. 125:310-316
Purpose To compare toxicity and survival after stereotactic body radiotherapy (SBRT) between lung cancer patients with or without idiopathic interstitial pneumonias (IIPs), and to investigate the potential value of SBRT for the patients. Methods Amon
Publikováno v:
Journal of Radiation Research
We previously reported that the local control of pulmonary metastases from colorectal cancer (CRC) following stereotactic body radiotherapy (SBRT) with moderate prescription dose was relatively worse. We investigated the treatment outcomes and toxici
Autor:
Yousuke Aoki, Atsuya Takeda, Noriyuki Saeki, Yohei Oku, Kae Yashiro, Takahisa Eriguchi, Tatsuji Enomoto, Tetsuya Yokosuka, Shuichi Nishimura, Tomikazu Mizuno, Yoshiaki Takagawa, Naoko Sanuki, Naoyuki Shigematsu
Publikováno v:
Journal of Radiation Research
To evaluate the outcomes and feasibility of stereotactic body radiotherapy (SBRT) for cT3 and cT4N0M0 non–small cell lung cancer (NSCLC), 25 patients with localized primary NSCLC diagnosed as cT3 or cT4N0M0, given SBRT between May 2005 and July 201
Autor:
Kotaro Matsunaga, Kento Imajo, Etsuo Kunieda, Hirotoshi Ebinuma, Hidetsugu Saito, Shogo Iwabuchi, Atsuya Takeda, Naoko Sanuki, Yousuke Aoki, Yuichiro Tsurugai
Publikováno v:
Cancer. 122:2041-2049
BACKGROUND Curative treatment options for patients with early stage hepatocellular carcinoma (HCC) include resection, liver transplantation, and percutaneous ablation therapy. However, even patients with solitary HCC are not always amenable to these
Autor:
Yohei Oku, Naoko Sanuki, Takeshi Akiba, Yousuke Aoki, Masaharu Shinkai, Etsuo Kunieda, Yuichiro Tsurugai, Tomikazu Mizuno, Yu Hara, Tatsuji Enomoto, Atsuya Takeda
Publikováno v:
Journal of thoracic disease. 10(1)
Background: Radiation pneumonitis is a critical pulmonary toxicity after irradiation of the lung. Macrolides including clarithromycin (CAM) are antibiotics. They also have immunomodulatory properties and are used to treat respiratory inflammatory dis
Autor:
Masaharu Shinkai, Yousuke Aoki, Takeshi Kaneko, Tatsuji Enomoto, Akihiko Kawana, Yu Hara, Takahisa Eriguchi, Shuichi Nishimura, Naoko Sanuki, Atsuya Takeda
Publikováno v:
Journal of Radiation Research
A major cause of death in patients undergoing long-term domiciliary oxygen therapy (LTOT) is lung cancer progression. In our institution, we actively perform stereotactic body radiotherapy (SBRT) on patients with early-stage non–small-cell lung can